nsv917557
- Organism: Homo sapiens
- Study:nstd75 (ClinGen Prenatal)
- Variant Type:copy number variation
- Method Type:Oligo aCGH
- Submitted on:NCBI36 (hg18)
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: Yes
- Region Size:293,448
- Publication(s):Wapner et al. 2012
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 1911 SVs from 90 studies. See in: genome view
Overlapping variant regions from other studies: 718 SVs from 58 studies. See in: genome view
Overlapping variant regions from other studies: 2203 SVs from 95 studies. See in: genome view
Overlapping variant regions from other studies: 710 SVs from 27 studies. See in: genome view
Variant Region Placement Information
Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nsv917557 | Remapped | Good | GRCh38.p12 | Primary Assembly | First Pass | NC_000015.10 | Chr15 | 22,813,994 | 23,107,441 |
nsv917557 | Remapped | Pass | GRCh38.p12 | ALT_REF_LOCI_1 | Second Pass | NT_187603.1 | Chr15|NT_1 87603.1 | 1 | 207,920 |
nsv917557 | Remapped | Good | GRCh37.p13 | Primary Assembly | First Pass | NC_000015.9 | Chr15 | 22,765,627 | 23,059,074 |
nsv917557 | Submitted genomic | NCBI36 (hg18) | Primary Assembly | NC_000015.8 | Chr15 | 20,316,991 | 20,610,515 |
Variant Call Information
Variant Call ID | Type | Sample ID | Method | Analysis | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Copy number |
---|---|---|---|---|---|---|---|---|
nssv1606327 | copy number loss | ISCA_ID_pn_1973 | Oligo aCGH | Probe signal intensity | Developmental delay AND/OR other significant developmental or morphological phenotypes | Likely pathogenic | Submitter | 1 |
Variant Call Placement Information
Variant Call ID | Placement Type | Score | HGVS | Assembly | Reciprocity | Sequence ID | Chr | Inner Start | Inner Stop |
---|---|---|---|---|---|---|---|---|---|
nssv1606327 | Remapped | Pass | NT_187603.1:g.(?_1 )_(207920_?)del | GRCh38.p12 | Second Pass | NT_187603.1 | Chr15|NT_1 87603.1 | 1 | 207,920 |
nssv1606327 | Remapped | Good | NC_000015.10:g.(?_ 22813994)_(2310744 1_?)del | GRCh38.p12 | First Pass | NC_000015.10 | Chr15 | 22,813,994 | 23,107,441 |
nssv1606327 | Remapped | Good | NC_000015.9:g.(?_2 2765627)_(23059074 _?)del | GRCh37.p13 | First Pass | NC_000015.9 | Chr15 | 22,765,627 | 23,059,074 |
nssv1606327 | Submitted genomic | NC_000015.8:g.(?_2 0316991)_(20610515 _?)del | NCBI36 (hg18) | NC_000015.8 | Chr15 | 20,316,991 | 20,610,515 |
No validation data were submitted for this variant
Clinical Assertions
Variant Call ID | Sample ID | HGVS | Type | Subject Phenotype | Clinical Interpretation | Source of Interpretation | Gender | Age | Copy number |
---|---|---|---|---|---|---|---|---|---|
nssv1606327 | ISCA_ID_pn_1973 | NCBI36: NC_000015.8:g.(?_20316991)_(20610515_?)del | copy number loss | Developmental delay AND/OR other significant developmental or morphological phenotypes | Likely pathogenic | Submitter | Female | 19 weeks gestation | 1 |